PRESS RELEASE published on 02/20/2023 at 12:01, 3 years 8 months ago Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
PRESS RELEASE published on 02/16/2023 at 13:00, 3 years 8 months ago EV Nickel Drilling on the High-Grade W4 Zone Hits Sulphide Intercepts on the First Two Holes and Extends Mineralized Zone to the East
PRESS RELEASE published on 02/14/2023 at 07:30, 3 years 8 months ago APONTIS PHARMA accelerates expansion of Single Pill portfolio with second of three in-licensing deals planned for 2023
PRESS RELEASE published on 02/09/2023 at 13:30, 3 years 9 months ago EV Nickel Initiates Drilling on the High-Grade W4 Zone, focused on the East Side of the Mineralization, to be Incorporated into the Upcoming Resource
PRESS RELEASE published on 02/06/2023 at 13:00, 3 years 9 months ago EV Nickel - Final Assays for CarLang A Zone- Reports 297.5 metres of 0.28% Ni. The A Zone Represents 20% of the Prosepective Trend
PRESS RELEASE published on 01/31/2023 at 07:30, 3 years 9 months ago APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill
PRESS RELEASE published on 01/12/2023 at 13:00, 3 years 9 months ago EV Nickel CarLang A Zone Continues to Expand - Preliminary Resource Estimate Planned for Spring 2023
PRESS RELEASE published on 01/11/2023 at 13:00, 3 years 9 months ago EV Nickel Confirms New High-Grade Ni-Cu Zone at Groves
Published on 11/10/2026 at 14:45, 2 hours 38 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 2 hours 52 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 2 hours 53 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 2 hours 53 minutes ago ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 3 hours 23 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 17:10, 13 minutes ago mySTAYINN Highlights the Growing Need for Contractor Accommodation Amid £2.1 Billion Highland Infrastructure Investment
Published on 11/10/2026 at 16:22, 1 hour 1 minute ago EQS-Adhoc: HomeToGo SE: HomeToGo Increases FY/26 Adjusted EBITDA Guidance to €48M - €50M; Confirms IFRS Revenue Guidance
Published on 11/10/2026 at 16:05, 1 hour 17 minutes ago Aurzen Brings Big-Screen Entertainment for Less This Black Friday and Cyber Monday
Published on 11/10/2026 at 15:10, 2 hours 12 minutes ago MICROIP Debuts at electronica 2026, Unveiling AI Drone and In-Vehicle Systems to Target European Edge AI Market
Published on 11/10/2026 at 15:05, 2 hours 17 minutes ago TEADIT® to break ground on Significant Facility Expansion
Published on 11/10/2026 at 14:00, 3 hours 22 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026
Published on 11/10/2026 at 14:00, 3 hours 22 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 6 hours 20 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 6 hours 20 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 10 hours 23 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
